Skip to main content

Carcinoid Intestine Tumor clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

    open to eligible people ages 18 years and up

    The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.

    at UCLA

Last updated: